Tag: pharmaceuticals
-
Biotech Licenses Mayo Clinic Microbiome Research
A biotechnology company developing therapies with specialized gut microbes is licensing research from the Mayo Clinic on these microbes’ effects with autoimmune diseases.
-
Trial Underway Testing Personal RNA Cancer Drug
A clinical trial is underway testing a treatment for solid tumor cancers derived from messenger RNA, genetic material with protein coding instructions for cells.
-
Two Opioid Addiction Treatments Found Safe, Effective
A clinical trial testing two leading therapies for opioid abuse found the treatments both safe and effective, even though they work in different ways.
-
Alliance Exploring Microbiome on Cancer Immunotherapy
A biotechnology company and two research institutes are collaborating on a study of a proposed cancer treatment that targets the microbiome, communities of bacteria in the human body.
-
FDA Clears First Sensor-Pill and App System
The Food and Drug Administration approved for the first time in the U.S. a system that combines pills with built-in sensors and a mobile app to track adherence.
-
Zymeworks, Janssen in $1.45B Antibody Licensing Deal
Janssen Biotech, a division of drug maker Johnson & Johnson, is acquiring technologies that make it possible to create synthetic antibodies that hit multiple targets.
-
Sanofi Acquires Multiple Sclerosis Drug in $800M Deal
Drug maker Sanofi is licensing a drug candidate from Principia Biopharma Inc. designed to treat multiple sclerosis, an autoimmune condition affecting the brain and nervous system.
-
Open-Source Model Devised to Value Medical Technologies
An initiative joining most major health care stakeholders is developing models to calculate the value of medical treatments, with a process described as open and transparent.
-
New Finance, Development Model for Pancreatic Disease
An organization is being formed to adopt performance-based financing and precision medicine to accelerate research and development on pancreatitis.
-
New Drug Shown to Reduce Depressive Behaviors
A new type of treatment for depression that works differently from most other anti-depressive drugs was shown in lab mice to reduce depression-like behaviors.